These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4575 related articles for article (PubMed ID: 220273)

  • 1. Evidence suggesting that a cyclic AMP-dependent protein kinase is a positive regulator of proliferation in Cloudman S91 melanoma cells.
    Pawelek JM
    J Cell Physiol; 1979 Mar; 98(3):619-25. PubMed ID: 220273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between insulin and the cyclic AMP system of Cloudman S91 mouse melanoma cells.
    Pawelek J; Emanuel J; Kahn R; Murray M; Fleischmann R
    J Cell Biochem; 1983; 21(4):289-97. PubMed ID: 6317705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
    Niles RM; Loewy B
    J Cell Physiol; 1991 Apr; 147(1):176-81. PubMed ID: 1645360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells.
    Lichti U; Gottesman MM
    J Cell Physiol; 1982 Dec; 113(3):433-9. PubMed ID: 6294128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adenosine 3',5'-monophosphate in the transformation of Cloudman mouse melanoma cells.
    Lincoln TM; Vaughan GL
    J Cell Physiol; 1975 Dec; 86(3 Pt 1):543-51. PubMed ID: 172519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of cyclic nucleotide regulation in protein-kinase-defective adrenal cells through somatic cell fusion.
    Schimmer BP; Horney SJ; Williams SA; Aitchison WA; Doherty PJ
    J Cell Physiol; 1984 Dec; 121(3):483-9. PubMed ID: 6094598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of mutant and wild type protein kinase in lymphoma cells resistant to dibutyryl cyclic AMP.
    Lemaire I; Coffino P
    J Cell Physiol; 1977 Sep; 92(3):437-45. PubMed ID: 198416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines.
    Chin KV; Chauhan SS; Abraham I; Sampson KE; Krolczyk AJ; Wong M; Schimmer B; Pastan I; Gottesman MM
    J Cell Physiol; 1992 Jul; 152(1):87-94. PubMed ID: 1352302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A variant of S49 mouse lymphoma cells with enhanced secretion of cyclic AMP.
    Steinberg RA; Steinberg MG; van Daalen Wetters T
    J Cell Physiol; 1979 Sep; 100(3):579-88. PubMed ID: 226556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE1-independent MDCK cells have elevated intracellular cyclic AMP but retain the growth stimulatory effects of glucagon and epidermal growth factor in serum-free medium.
    Taub M; Devis PE; Grohol SH
    J Cell Physiol; 1984 Jul; 120(1):19-28. PubMed ID: 6203919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of proliferation of cloudman S91 melanoma cells by insulin and characterization of some insulin-resistant variants.
    Kahn R; Murray M; Pawelek J
    J Cell Physiol; 1980 Apr; 103(1):109-19. PubMed ID: 7000797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
    Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
    Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells.
    Shuntoh H; Steinberg RA
    J Cell Physiol; 1991 Jan; 146(1):86-93. PubMed ID: 1846638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and analysis of melanoma cell mutants resistant to the antiproliferative action of retinoic acid.
    Lotan R; Stolarsky T; Lotan D
    Cancer Res; 1983 Jun; 43(6):2868-75. PubMed ID: 6850598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered cyclic AMP-dependent protein kinase activity in a mutant adrenocortical tumor cell line.
    Gutmann NS; Rae PA; Schimmer BP
    J Cell Physiol; 1978 Dec; 97(3 Pt 2 Suppl 1):451-60. PubMed ID: 215599
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of adenosine 3':5'-monophosphate-dependent protein kinase activation and inhibition of thymidine incorporation into DNA in P1798 lymphosarcoma cells.
    Michnoff CA; de la Houssaye BA; Masaracchia RA
    Cancer Res; 1983 Aug; 43(8):3514-20. PubMed ID: 6305487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse lymphoma cells with mutations of cyclic AMP-dependent protein kinase.
    Coffino P
    Natl Cancer Inst Monogr; 1978 May; (48):377-80. PubMed ID: 219362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between cyclic AMP- and phorbol ester-dependent phosphorylation systems in S49 mouse lymphoma cells.
    Kiss Z; Steinberg RA
    J Cell Physiol; 1985 Nov; 125(2):200-6. PubMed ID: 2997237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1.
    Guo N; Zabrenetzky VS; Chandrasekaran L; Sipes JM; Lawler J; Krutzsch HC; Roberts DD
    Cancer Res; 1998 Jul; 58(14):3154-62. PubMed ID: 9679984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a variant of B16-mouse melanoma resistant to MSH growth inhibition.
    Niles RM; Logue MP
    J Supramol Struct; 1979; 11(2):251-8. PubMed ID: 232892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 229.